Idaho Molecular Inc

Experience, Expertise, Innovation, Passion

We use biotechnology to improve human lives.


Devices that help labs, hospitals, and research facilities make data driven decisions.


Cutting edge genetic research and development that is increasing the utility of DNA and RNA for health sciences.


Complicated chemistry encapsulated into an approachable, easy-to-use package.

Medical science has proven time and again that when the resources are provided, great progress in the treatment, cure, and prevention of disease can occur.

Michael J. Fox

About Us

Team decisions are best made on a mountain and not in a board room.

Kirk Ririe, CEO

Idaho Molecular

Our People

Dr. Kirk Ririe CEO

Principle inventor of the FilmArray system and founder of BioFire Diagnostics.

Carl T. Wittwer, MD, PhDCMO

Former director of Immunologic Flow Cytometry at ARUP and co-founder of BioFire Diagnostics.

Mark Poritz, PhD CSO

Principal Investigator on the NIH grant that funded the development of BioFire’s FilmArray system.

Jacob Ulrich Director of Finance

Finance and procurement specialist with over three years experience at JP Morgan Chase bank.

Christopher Thurston CTO

Architect of next generation COVID testing system and Syndromic Trends.


Company Updates and Announcements

Headquarters Established

Idaho Molecular Inc. is pleased to announce that we have established headquarters in Salt Lake City, Utah. Our building is centrally located in the Salt Lake Valley at 3175 S 300 W, South Salt Lake, UT 84115.

Dr. Carl Wittwer Joins Idaho Molecular

Idaho Molecular Inc. is pleased to announce that Carl T. Wittwer, MD, PhD has joined our management team serving jointly as our Co-Chairman and Chief Medical Officer.

Idaho Molecular Incorporates

Idaho Molecular Inc. incorporates April 1st, 2020 to bring innovative and novel solutions to human health using biotechnology.

Our experience


Reach out


Idaho Molecular Inc.
3175 S 300 W
South Salt Lake, UT 84115